Serotonin syndrome
SSRI plus MAOI combinations flag at order entry. Tramadol, linezolid, and methylene blue also surface. The check fires before the prescription leaves the encounter sidebar.
ePrescribe
Prescribe in the encounter, not in another tab.
Surescripts-certified prescribing inside the same workspace as the chart. Real-time benefit checks, EPCS for controlled substances, and interaction checks tuned for the combinations psych and addiction-medicine clinicians actually prescribe.
ePrescribe is a paid workspace add-on. Pricing is per provider. Surescripts onboarding, EPCS identity proofing, and two-factor enrollment are handled inside the platform. Most solo and small group practices are prescribing within a week of going live.
Already on Nextvisit? Add ePrescribe from the workspace settings. Sign in to enable.
From order entry to pharmacy in one card.
Pick the drug, watch the safety and benefit checks resolve, review the pharmacy route, and send. The whole loop sits inside the encounter sidebar, no second tab.
Patient M.G.
Sertraline HCl 100 mg oral tablet
1 tab PO daily · qty 30 · 1 refill
- AllergiesNKDA on file. No conflicts with sertraline.
- Drug interactionsCross-checked 4 active meds (alprazolam, lithium, propranolol, melatonin). No critical interactions.
- Dose for age and indication50 mg → 100 mg titration appropriate for adult MDD per FDA labeling.
- QTc advisoryBaseline ECG advised if escalating beyond 200 mg or combining with other QT-prolonging agents.
- EPCS not requiredSchedule IV. Standard e-prescribe path applies.
Aetna PPOTier 1$0 copayNo prior auth
SurescriptsCVS Pharmacy #04321
Sample is illustrative. Real prescriptions show the actual patient roster, the actual insurance plan on file, and the actual pharmacy preferences.
Built around the prescribing patterns that matter.
The interaction database is tuned for the combinations behavioral-health clinicians actually prescribe, so the alerts focus on real risk instead of generic family-medicine noise.
Lithium toxicity
NSAID, ACE inhibitor, and thiazide combinations prompt a level-check reminder. The system also tracks lithium level cadence per the dosing pattern on file.
QT prolongation
Citalopram, ziprasidone, methadone, and combinations among them trigger a QTc advisory with a baseline ECG suggestion when escalation is planned.
Buprenorphine and benzodiazepines
Combination is not contraindicated, but the system surfaces the elevated overdose risk and the documentation requirements at order entry.
Controlled substances, end to end.
Schedule II to V controlled substances are e-prescribable through Nextvisit. Two-factor at send, audit log on every action, regulator-ready records.
- Two-factor required at every controlled-substance prescription.
- Immutable audit log of every send, retraction, and refill.
- Schedule II prescriptions for stimulants, opioids, and benzodiazepines.
- DEA 21 CFR 1311 EPCS rule compliant.
The cost question, answered before send.
The benefit response comes back at order entry, not after the patient is at the pharmacy counter. Tier, copay, prior auth, and alternatives all surface in one pill.
- Formulary tier surfaced at order entry.
- Copay estimate (covered amount, deductible status, OOP impact).
- Prior authorization flag with the form pre-populated when PA is required.
- Therapeutic alternatives suggested when the chosen drug is not covered.
Buprenorphine, naltrexone, methadone, no extra dance.
The X-waiver was eliminated by the Mainstreaming Addiction Treatment Act in December 2022. Standard DEA registration plus the 8-hour MAT training is enough. Buprenorphine, naltrexone, and methadone are all e-prescribable.
Most behavioral-health clinicians are now MAT-eligible by default. Nextvisit handles the EPCS path for buprenorphine (Schedule III), the prior-auth checks for some payers, and the documentation requirements that show up in 42 CFR Part 2 audits. For clinicians running a dedicated MAT panel, the workflow ties to the cohort tags and outcome tracking documented on the MAT solutions page .
Common questions about ePrescribe.
Nextvisit ePrescribe is the prescribing module inside the Nextvisit workspace. It is Surescripts-certified, supports EPCS for controlled substances Schedule II to V, runs interaction and dose-for-age checks tuned for behavioral-health prescribing, and routes the prescription directly to the patient's chosen pharmacy.
Yes. EPCS is supported for Schedule II to V. Two-factor authentication is required at every send. The audit log is immutable and meets the DEA's 21 CFR 1311 EPCS rule. Common Schedule II prescribing in behavioral health includes stimulants, certain benzodiazepines (in some states), and the buprenorphine/naloxone combinations classed at Schedule III.
Yes. The X-waiver was eliminated in December 2022 by the Mainstreaming Addiction Treatment Act, so any clinician with a standard DEA registration and the 8-hour MAT training can prescribe buprenorphine. Nextvisit handles the EPCS path, the interaction checks, and the documentation requirements common to MAT visits.
Nextvisit cross-references the new prescription against the patient's active medication list at order entry. The interaction database is tuned for combinations that show up in psych and addiction medicine, so the alerts focus on serotonin syndrome risk, lithium toxicity factors, QT prolongation, and benzodiazepine plus opioid combinations rather than generic family-medicine noise.
Yes. Real-time benefit check fires at order entry. The response includes formulary tier, copay estimate, prior-authorization flag, and therapeutic alternatives if the chosen drug is not covered. The PA form is pre-populated when one is needed.
Any pharmacy that accepts Surescripts e-prescriptions, which covers nearly every retail and mail-order pharmacy in the United States. The Surescripts network includes the major chains (CVS, Walgreens, Walmart, Rite Aid, Kroger), independent pharmacies, and mail-order pharmacies. Patients can pick their preferred pharmacy at any visit.
Standard Surescripts onboarding, which Nextvisit handles for the workspace. EPCS requires identity proofing and two-factor enrollment per provider, also handled inside the platform. Most solo and small group practices are prescribing within a week of going live; enterprise and academic sites that need credentialing-board sign-off run on their own timeline.
Try it next visit
Twenty minutes, one mock visit. You leave with a note in your template.
Sign your account up, enable ePrescribe, and run an EPCS send against a sandbox pharmacy in your first week. We will not be offended if it does not stick, but most prescribers do not go back.
Live in 2 weeks or less BAA signed by default 30-day money back